Environmental Decontamination

BEHAVIORAL2 trials

Sponsors

University of North Carolina, Chapel Hill

Conditions

Cystic FibrosisMethicillin-resistant Staphylococcus Aureus

Phase 2

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

TerminatedNCT01349192

University of North Carolina, Chapel HillCystic Fibrosis, Methicillin-resistant Staphylococcus Aureus

Start: 2011-04-30End: 2015-05-31Updated: 2017-05-15

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

CompletedNCT03489629

University of North Carolina, Chapel HillCystic Fibrosis

Start: 2018-04-03End: 2026-01-31Updated: 2026-02-17

Related Papers

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial

UNC Libraries2020-04-22

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial

Thorax2016-11-1559 citations